Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan
CompletedNCT03981809
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Development and internal validation of an easy-to-use tool for clinical pain assessment. The tool has to be applicable in any clinical practice and without the need for expensive and complicated hospital tools to identify the source of persistent pain after the treatment of cancer.
Study details
- Official title
- Development and Validation of a Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors With Persistent Pain
- Conditions
- Cancer Survivors
- Cancer Pain
- Interventions
- Diagnostic test: Diagnostic test ("PainsCan") for the identification of the dominant pain mechanisms in cancer survivers with persistent pain
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Collaborators
- Fund for Scientific Research, Flanders, Belgium
- Start date
- 2019-06-13
- Primary completion
- 2022-12-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Belgium
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patient treated for primary cancer: breast, prostate, lung/bronchus, colon/rectum, gynecologic (uterus or ovary) * Complete remission * Curative treatment finished * Ongoing hormonal and targeted treatment permitted * Patient experiences pain (NRS minimum 3/10 during the past week) Exclusion Criteria: * Active metastasis * Palliative status * Other type of cancer than mentioned in inclusion criteria * Pregnancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03981809